LMX4 may be available in the countries listed below.
UK matches:
Lidocaine is reported as an ingredient of LMX4 in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Taximax may be available in the countries listed below.
Cefotaxime sodium salt (a derivative of Cefotaxime) is reported as an ingredient of Taximax in the following countries:
International Drug Name Search
Tilsan may be available in the countries listed below.
Maprotiline hydrochloride (a derivative of Maprotiline) is reported as an ingredient of Tilsan in the following countries:
International Drug Name Search
Rami-Q may be available in the countries listed below.
Ramipril is reported as an ingredient of Rami-Q in the following countries:
International Drug Name Search
Carbadura may be available in the countries listed below.
Carbamazepine is reported as an ingredient of Carbadura in the following countries:
International Drug Name Search
Bezpa may be available in the countries listed below.
Drotaverine hydrochloride (a derivative of Drotaverine) is reported as an ingredient of Bezpa in the following countries:
International Drug Name Search
Balsoclase Antitussivum Jeune Enfant may be available in the countries listed below.
Pentoxyverine citrate (a derivative of Pentoxyverine) is reported as an ingredient of Balsoclase Antitussivum Jeune Enfant in the following countries:
International Drug Name Search
Treating moderate to severe pain in certain patients.
Oxymorphone is an opioid (narcotic) analgesic. It works by binding to certain receptors in the brain and nervous system to reduce pain.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Oxymorphone. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Oxymorphone. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Oxymorphone may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Oxymorphone as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Oxymorphone.
When used for long periods of time or at high doses, Oxymorphone may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if Oxymorphone stops working well. Do not take more than prescribed.
Some people who use Oxymorphone for a long time may develop a need to continue taking it. People who take high doses are also at risk. This is known as DEPENDENCE or addiction. Dependence is unlikely to be an issue in terminally ill patients where comfort is more important. If you are taking Oxymorphone regularly, do not suddenly stop taking it without checking with your doctor. WITHDRAWAL symptoms have occurred when Oxymorphone is suddenly stopped and may include anxiety; diarrhea; fever, runny nose, or sneezing; goose bumps and abnormal skin sensations; nausea and vomiting; pain; rigid muscles; seeing, hearing, or feeling things that are not there; shivering or tremors; sweating; and trouble sleeping. Contact your doctor if you notice any of these symptoms after stopping Oxymorphone.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Anxiety; constipation; dizziness; drowsiness; dry mouth; gas; headache; lightheadedness; nausea; sweating; vomiting.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); confusion; fainting; fast, slow, or irregular heartbeat; fever; hallucinations; mental or mood changes; seizure; severe or persistent dizziness or drowsiness; severe or persistent headache or vomiting; shallow, slowed, or difficult breathing; trouble urinating; unusual swelling; vision changes.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Oxymorphone side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include bluish skin; chest pain; cold and clammy skin; coma; difficult or slow breathing; limp muscles; numbness of an arm or leg; pinpoint pupils; severe drowsiness or dizziness; slow or irregular heartbeat.
Store Oxymorphone at 77 degrees F (25 degrees C). Store away from heat, moisture, and light. Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Do not store Oxymorphone in the bathroom. Keep Oxymorphone out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Oxymorphone. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Pyridoxine Hydrochloride (BANM, JAN) is known as Pyridoxine in the US.
International Drug Name Search
Glossary
| BANM | British Approved Name (Modified) |
| JAN | Japanese Accepted Name |
In some countries, this medicine may only be approved for veterinary use.
In the US, Desmopressin (desmopressin systemic) is a member of the drug class antidiuretic hormones and is used to treat Diabetes Insipidus, Hemophilia A, Primary Nocturnal Enuresis and von Willebrand's Disease.
US matches:
UK matches:
Rec.INN
H01BA02
0016679-58-6
C46-H64-N14-O12-S2
1069
Hemostatic agent
Analogue of vasopressin (antidiuretic hormone, ADH)
(2S)-N-[(2R)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)1,2-dithia-5,8,11,14,17-pen (IUPAC)
(3-Sulphanylpropanoyl)-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-D-arginylglycinamide cyclic (1→6)-disulfide (Ph. Eur.)
[1-Deamino-8-D-arginine]vasopressin (BAN)
1-(3-mercaptopropionic acid)-8-argininevasopressin (WHO)
Vasopressin, 1-(3-mercaptopropanoic acid)-8-D-arginine-
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IUPAC | International Union of Pure and Applied Chemistry |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Ph. Eur. | European Pharmacopoeia |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Ectiva may be available in the countries listed below.
Sibutramine is reported as an ingredient of Ectiva in the following countries:
Sibutramine hydrochloride monohydrate (a derivative of Sibutramine) is reported as an ingredient of Ectiva in the following countries:
International Drug Name Search
Cephorum may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Cefalexin is reported as an ingredient of Cephorum in the following countries:
International Drug Name Search
Bromhexin Clorhidrat may be available in the countries listed below.
Bromhexine hydrochloride (a derivative of Bromhexine) is reported as an ingredient of Bromhexin Clorhidrat in the following countries:
International Drug Name Search
Benzil benzoat Jadran may be available in the countries listed below.
Benzyl Benzoate is reported as an ingredient of Benzil benzoat Jadran in the following countries:
International Drug Name Search
Bilol comp. may be available in the countries listed below.
Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Bilol comp. in the following countries:
Hydrochlorothiazide is reported as an ingredient of Bilol comp. in the following countries:
International Drug Name Search
Bromhexin ACO may be available in the countries listed below.
Bromhexine hydrochloride (a derivative of Bromhexine) is reported as an ingredient of Bromhexin ACO in the following countries:
International Drug Name Search
Codenfan may be available in the countries listed below.
Codeine is reported as an ingredient of Codenfan in the following countries:
Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Codenfan in the following countries:
International Drug Name Search
Brogal may be available in the countries listed below.
Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Brogal in the following countries:
International Drug Name Search
Tulos may be available in the countries listed below.
Lactulose is reported as an ingredient of Tulos in the following countries:
International Drug Name Search
Fibrinogen, human is reported as an ingredient of RiaSTAB in the following countries:
International Drug Name Search
Biazol may be available in the countries listed below.
Bifonazole is reported as an ingredient of Biazol in the following countries:
International Drug Name Search
Tamsulosine HCl Yamanouchi may be available in the countries listed below.
Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Tamsulosine HCl Yamanouchi in the following countries:
International Drug Name Search
Klerimed may be available in the countries listed below.
Clarithromycin is reported as an ingredient of Klerimed in the following countries:
International Drug Name Search
